Clinical Trials Logo

Oral Parasitic Drug clinical trials

View clinical trials related to Oral Parasitic Drug.

Filter by:
  • None
  • Page 1

NCT ID: NCT02841215 Completed - Ivermectin Clinical Trials

Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies

GALECRUSTED
Start date: October 11, 2017
Phase: Phase 3
Study type: Interventional

Severe forms of scabies (crusted scabies and profuse scabies) require a specific treatment. Ivermectin is a recommended treatment in common forms of scabies and represents a promising treatment in crusted scabies in case reports. However, response to ivermectin remains variable among studies, and there is no consensus on the schemes to adopt (dosages and administrations). Ivermectin at 400 µg/kg has already been used, without showing toxicity (in head lice treatment in particular). Investigators propose to demonstrate that 400µg/kg ivermectin dosage will show better efficacy than a 200µg/kg in patients with severe forms of scabies (crusted and profuse).